key: cord-0952003-v400nb8c
authors: Kumar, Sachin; Khokra, Sukhbir Lal; Yadav, Akash
title: Triazole analogues as potential pharmacological agents: a brief review
date: 2021-05-25
journal: Futur J Pharm Sci
DOI: 10.1186/s43094-021-00241-3
sha: 3c8a7842ba3a64b87f3232acd641f21caeb14c5f
doc_id: 952003
cord_uid: v400nb8c

BACKGROUND: A large number of studies have recently reported that, because of their significant biological and pharmacological properties, heterocyclic compounds and their derivatives have attracted a strong interest in medicinal chemistry. The triazole nucleus is one of the most important heterocycles which has a feature of natural products as well as medicinal agents. Heterocyclic nitrogen is abundantly present in most medicinal compounds. The derivatization of triazole ring is based on the phenomenon of bio-isosteres in which substituted the oxygen atom of oxadiazole nucleus with nitrogen triazole analogue. MAIN TEXT: This review focuses on recent synthetic procedure of triazole moiety, which comprises of various pharmacological activities such as antimicrobial, anticonvulsant, anti-inflammatory, analgesic, antitubercular, anthelmintic, antioxidant, antimalarial, antiviral, etc.. CONCLUSION: This review highlights the current status of triazole compounds as different multi-target pharmacological activities. From the literature survey, triazole is the most widely used compound in different potential activities.

In the field of research and the synthesis of new bioactive molecule, heterocyclic chemistry plays the most important role. Medicinal chemistry is a part of the medical and pharmaceutical sciences, is concerned with the development and design, and credits the significant biologically active drug molecule. The most active biological activities have been shown among these heterocyclic molecules containing nitrogen and oxygen. Many different compounds have been prepared and exhibit different types of useful pharmacological activity [1] .

To investigate a new agent is one of the most difficult tasks for the medicinal chemist. Synthesis of heterocyclic systems consisting high nitrogen has been rising over the past decade owing to their usefulness in different applications such as propellants, explosives, pyrotechnics, and especially chemotherapy. In recent years, considerable attention has been received by the chemistry of triazoles and their fused heterocyclic derivatives because of their synthetic and effective biological importance [2] .

Azolic derivatives such as thiazole, triazole, oxadiazole, and thiadiazole are pharmacologically active compounds and, due to their effective use in medicinal chemistry, have been intensely studied for various biological activities [3] .

Triazole Triazole is a five-member heterocyclic ring containing two carbon and three nitrogen atoms with molecular formula C 2 H 3 N 3 [4] . And it is found in two isomeric forms, 1,2,3triazole and 1,2,4-triazole, which are also known as pyrrodiazole. (Fig. 1) .

Triazoles are white-to-pale yellow crystals with a weak odour, soluble in water and alcohol at a melting point of 120°C and 260°C [5] . In medicinal chemistry, fivemember heterocyclic nitrogen-containing compounds such as triazole are of great importance due to their wide range of biological applications such as anticonvulsant [6, 7] , antimicrobial [8, 9] , antiviral [10, 11] , antitubercular [12] , antidiabetic [13] , anti-inflammatory [14, 15] , antiproliferative [16] [17] [18] , antioxidant [19] , anti-urease [19] , and antimalarial activities [20, 21] . (Fig. 2) .

The article gives a brief review of the synthetic procedure and characterization of triazole and its pharmacological activity.

Lu yang et al. reported 4-acyl-NH-1,2,3-triazole synthesis by the use of water-mediated cycloaddition reactions of enaminone and tosilazide, requiring both a mild condition (40°C) and practical scalability, when using the water as sole medium without any catalyst (Scheme 1) [22] .

Shelke et al. had synthesized and found that, in the absence of a catalyst, the substitution of 1,2,4 triazole from hydrazine and formamide under microwave irradiation and this reaction effectively indicates excellent functional group tolerance (Scheme 2) [23] .

Bechara et al. reported the synthesis of 3,4,5-Trisubstituted 1,2,4-triazole from 2 o amides and hydrazides by triflic anhydride activation followed by the microwave cyclodehydrationto be1,2,4-Triazole moiety is a useful leading group of Ru-catalyzed C-H arylation (Scheme 3) [24] .

Yin et al. synthesized a substituted triazole by one pot cyanoimidation of aldehydes where cyanamide as nitrogen source and the NBS as an oxidant in high yield without any catalyst. The substituted product N-cyanobenzimidate may also be subjected to a cyclization reaction to produce a high yield of 1,2,4-triazole derivative (Scheme 4) [25] .

Faldiman et al. reported 1,4 disubstituted 1,2,3 triazoles from azides. These are obtained with excellent yield from aromatic and aliphatic halides that are easily available without formation of potentially unstable organic azide intermediates (Scheme 5) [26] .

Liu et al. reported a novel substituted 3,5-diamine-1,2,4triazole from isothiocynate and mono-substituted hydrazines and sodium hydrogen cyanamide (Scheme 6) [27] . Zhengkaichen et al. reported a metal-free synthesis of 1,3, 5-trisubstituted-1,2,4-triazoles in the presence of iodine as catalyst (Scheme 7). And it can be synthesized from hydrazones and aliphatic amines under oxidative conditions via a cascade C-H functionalization, double C-N bond formation, and oxidative aromatization [28] .

This article presented discusses a brief description of the various triazole activities, and the recent studies have showed the wide range of pharmacological activities available for triazole derivatives which may be divided into the following categories:

Fabrice et al. synthesized a novel series of 1,2,4-triazole-indole hybrids and evaluated their antifungal activity. All the synthesized hybrids were characterized by IR, NMR, and mass and elemental spectroscopy. The compound (2-(2,4-Dichlorophenyl)-3-(1H-indol-1-yl)-1-(1,2,4-1H-triazol-1-yl) propan-2-ol 1a exhibited the excellent activity against Candida, particularly against low fluconazole susceptible species. Result showed that this compound exhibited high activity as compared with fluconazole and similar to voriconazole against C. glabrata, C. krusei, and C. albicans [29] .

Wujec et al. synthesized the ten compounds which contain the manic base-1,2,4 triazole. The broth microdilution technique was used against Grampositive and Gram-negative bacteria to evaluate antimicrobial activity of these compounds. The phenyl ring present in the 4-position of piperazine appears essential for antibacterial action. Compound 2a showed the potent activity with MIC value 30 μg/mL against M. luteus and 60 μg/mL against three different bacterial strains (B. subtilis, S. aureus, and S. epidermidis) [30] .

Lipeeva et al. synthesized and investigated a novel series of 1,2,3-triazole-substituted coumarins and tested their in vitro antimicrobial activity against four different bacterial strains. Result showed that compounds 3a, 3b, and 3c showed potent activity against S. aureus strains with MIC values ranging between 0.16 and 0.41 μg/mL as compared with the reference drug ceftriaxone and streptomycin. The structure activity relationship of compound (carboxamidotriazolylbenzoic acid) substitution at position C-6 of coumarin core displayed promising activity towards A. viscosus as compared with compound 3b. The compound 3b with triazolylbenzoic acid substitute in the C-7 position exhibited highest activity towards the bacterial strains of S. aureus "Viotko", and compound 3c with the substitution of 3-ethynylcoumarin with methylanthranilate exhibited remarkable antibacterial activity against the strains of S. aureus [31] . Tingjunhong Ni et al. synthesized twenty-seven triazole derivatives containing alkynyl side chains, and their antifungal activity towards Cryptococcus and Candida species were evaluated as compared with reference drugs. The results showed that the compounds 5a and 5b demonstrated in vitro activity towards all fungi with MIC 80 values in range between 0.0156 and 0.5 μg/mL, higher than ravuconazole and fluconazole. Structural relationships showed the introduction of fluoro, chloro, and cyano groups at p-position of phenyl alkynyl or pyridinyl alkynyl side chain enhances their antifungal activity [33] .

Yang et al. synthesized the derivatives of quinazoline (E)-2-(4-(1H-1,2,4-triazol1-yl) as an antimicrobial agent. Among these compounds, in vitro antimicrobial activity was evaluated against three phytophatogenic bacteria (Xac, Xoo, and Rs) as compared with the reference bismerthiazole (BMT) drug. Among them, compounds 6a, 6b, and 6c showed better antibacterial activity against pathogen Xac and its EC 50 values are 53.2, 67.7, and 70.7 μg/mL. And the antifungal activity also evaluated against the three phytopathogenic fungi. Result revealed that the compounds 6c, 6d, 6e, and 6f showed the modest inhibition activities with EC 50 values 45.7 ± 1.8, 40.7 ± 2.1, 43.6 ± 1.7, and 43.1 ± 2.1 respectively against S. sclerotiorum with the reference of Hymexazol at 50 μg/mL, having > 40% inhibition rate [34] where value of R in 6a. R = C(CH3)3C6H4, 6b. R = 2,6 -Cl2C6H3, 6c. R = 4 -FC6H4, 6d. R = CH3, 6e. R = (CH2)2CH3, 6f. = C6H5.

Rezki et al. reported and investigated a novel series of 2,5-disubstituted thiadiazole clubbed 1,2,4-triazole as a potential antimicrobial agent. All derivatives were characterized by IR, 1 H-NMR, 13 C-NMR, MS, and elemental analysis. In vitro inhibitory growth activities of three Gram-positive (+) bacteria, three Gramnegative (-) fungi, and three strains of normal pathogenic microorganism strains were tested of all these compounds. SAR studies revealed the presence of phenyl or alkyl substitution at N-4 has enhanced their antimicrobial activity towards strains of bacteria and fungi with MIC values of 8-16 μg/mL, where ciprofloxacin and fluconazole are the reference drugs (Table 1) . Compounds 7a-7c were found to be the most potent antimicrobial agent [35] .

Tijenonkol et al. reported the 3-[1(2H)-phthalazinone-2yl(substituted)-4-aryl-1,2,4-triazole-5-thione derivatives and evaluated their antibacterial activity and screened them against Gram (+) & Gram (-) bacterial strains and fungal strains by using the broth microdilution method. Result revealed that the compounds 8a-8e exhibited the antibacterial activity is 25% against B. subtilis. And the antifungal activity of compound 8c was found to be 25% against C. albicans. The MIC value of compound 8e towards C. albicans and C. parapsilosis was 64 μg/mL & 32 μg/mL, and compound 8d was active towards C. parapsilosis with MIC value 32 μg/mL (Table 2 ) [36] .

Turan-Zitouni et al. synthesized 4-phenyl-cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido] thio-4H-1,2,4-triazole analogues and tested their antimicrobial activity. Among these synthesized compounds, only compound 9a showed excellent antifungal activity [37] . Hussain et al. synthesized eleven 1,4-disubstituted-1,2,3-triazole derivatives for antibacterial activity. All the synthesized derivatives were characterized spectroscopically, and their activities were evaluated. And the preliminary results of the synthesized derivatives showed the high inhibitory effects compared with the control ciprofloxacin. Result showed that the compounds 10a and 10b were found to be potent (MIC: 5 μg/mL, MIC: 10 μg/mL respectively) antibacterials against various strains of bacteria. And the docking studies showed that the most potent is compound 10a, exhibiting high binding energy and inhibition constant [38] .

Han et al. reported a new series of triazole derivatives containing different ester skeletons and evaluated as antifungal agents. The antifungal activity was investigated by utilizing the microdilution broth method. In all the synthesized compounds, compounds 11a and 11b showed the most significant activity against four important fungal pathogens (MIC 80 = 2-8 μg/mL). Molecular docking studied revealed the target compounds interact with CYP51 mostly by Van der Waals and hydrophobic interactions [39] .

Al-blewi et al. synthesized a novel series 1,4-disubstituted-1,2,3-triazole-sulfonamide hybrids and evaluated for their antimicrobial activity. All the synthesized hybrids were verified by mean of spectroscopic analysis. From the result, only compound 12a showed the most significant activity with MIC value range between 32 and 64 μg/mL as compared with the standard drug [40] .

Ramprasad et al. reported nineteen derivatives of quinoline-triazole hybrids and screened their antitubercular activity against Mycobacterium bovis. Result revealed that two derivatives, 13a and 13b, showed the potent antitubercular activity with MIC values 31.5 μm and 34.8 μm. SAR studies revealed that these compounds are essential for their activity due to n-octyl and 3-fluorophenyl groups presented on 1,2,3-triazole ring [41] . [2,3-d] pyrimidine-1,2,3-triazole derivatives for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv strain. All synthesized hybrids exhibited significant antitubercular activity. Among these series, compounds 15a and 15b showed the remarkable MIC value 0.78 μg/mL. The molecular docking results to the exhibition of high Moldock score of these compounds. SAR studies showed that the triazole ring substituted with heteroaryl compound containing highly electronegative atoms also enhance their activity [43] . significant activity (MIC = 1.56 μg/mL), in contrast with its antimicrobial activity [45] .

Kharb et al. investigated fifteen novel imidazolecontaining triazole derivatives and screened their anthelmintic activity towards Pheretimaposthuma at concentrations of 0.150% and 0.300% w/v respectively as compared with the albendazole as positive control. Result revealed that, the compound 18a displayed significant anthelmintic activity as compared with the reference drug [46] .

Gupta et al. reported five derivatives and evaluated for their anthelmintic activity against P. posthuma. From the result, compound 19a showed the potent vermicidal activity, and it exhibited the maximum paralysis time and 37.33 min of death time at 20 mg/mL concentration [47, 48] .

Satyendra et al. synthesized novel di-chloro substituted benzoxazole-triazolo-thione derivatives, and their anthelmintic activities were evaluated. Among them, the compound 20a exhibited the potent anthelmintic activity against P. posthuma as compared with the reference albendazole at 1% concentration [49] .

Verma et al. reported a series of novel 4,5-disubstituted-2,4dihydro-3H-1,2,4-triazole-3-thione derivatives for anticonvulsant activity. Anticonvulsant activity of compound wastes by maximal electroshock (MES), subcutaneous pentylenetetrazol (scPTZ) test in mice and rat and neurotoxicity screened at 30, 100, and 300 mg/kg dose and was suspended in 30% PEG 400 by an oral route to the mice. Among all these compounds, only compound 21a exhibited significant anticonvulsant activity at 300 mg/kg at a 4-h duration [50] . Zhang et al. synthesized a new series 3,4-dihydroisoquinolin containing 1,2,3-triazole compounds and investigated their anti-epileptic activity by using MES (maximal electroshock) and PTZ (pentylenetetrazole)induced seizure test. Among the synthesized compound, only compound 23a showed excellent antiepileptic activity with ED 50 value 48.19 mg/kg. It was found to be more active than valproate but less active than carbamazepine [52] . Siddiqui et al. synthesized various triazoles containing thiazole derivatives. The two most active compounds 47 and 48 were tested in the Phase II anticonvulsant study for their anticonvulsant activity (ED 50 ) and neurotoxicity (TD 50 ). And anticonvulsant action was carried out by two methods mostly using the electroshock (MES) and chemo shock (scPTZ) models. From the result, compounds 28a and 28b exhibited the potent anticonvulsant activity [57] .

Zheng et al. synthesized a novel series of 4-(4-substitutedphenyl)-3-methyl-1H-1,2,4-triazole-5(4H)-one derivatives and evaluated their anticonvulsant activity. All the synthesized derivatives were characterized by NMR, IR, and mass spectroscopy. Among the series, compound 29a was found to have the most promising activity with ED 50 value of 25.5 mg/kg [58] . Syed Shaf et al. reported a novel series of bis-hetero cycles containing 2-mercapto benzothiazole-based 1,2,3triazole and screened their anti-inflammatory activity. From the result, compound 37a display the significant selective COX-2 inhibition activity as compared with the standard drug and compound 37b also exhibited the comparable analgesic activity [66] .

Gamal El-Din A.A. et al. described a novel series of 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives. All the synthesized derivatives were confirmed by different spectroscopic method. Among the tested series, compounds 38a, 38b, 38c, and 38d exhibited potent anti-inflammatory activity. SAR studies demonstrated that the substitution of 4-methoxyphenyl (38a), 4-methylphenyl (38b), 4-acetylphenyl (38c), and 3,4-dimethoxyphenyl (38d) groups also increase antiinflammatory activity as compared with the other derivatives [67] .

Tozkoparan et al. synthesized a novel series of 5-aryl-3alkylthio-1,2,4-triazole derivatives and screened their antiinflammatory activity. All the synthesized derivatives were characterized by spectral and elemental analysis. Among the series, compounds 39a and 39b exhibited potent analgesic and antiinflammatory activities with no ulcerogenic effect [68] .

Kaur et al. described a novel series of 1,4-diaryl-substituted triazoles was synthesized and evaluated for their COX-2 inhibition. From the result, only compound 40a displayed excellent COX-2 activity [69] .

Mahanti et al. reported a series of fused acridine containing 1,2,4-triazole derivatives. And screened their anti-proliferative activity towards several human cell lines including, MCF7 (Breast), A549 (Lung), A375 (Melanoma), and HT-29 (Colon). The IC 50 value of target compound in range between 0.11 ± 0.02 and 13.8 ± 0.99 μM as compared with the standard range 0.11 ± 0.02 to 0.93 ± 0.056 μM. Result revealed that the compounds 41a-41c exhibited the excellent anticancer activity. SAR investigations of this series revealed that introduction of 4-chloro, 3,4,5-(CH 3 O) 3 , and 4-CF 3 CH 3 groups at para-position of the phenylring displayed the significant anticancer activity [70] . Ma et al. reported a novel series of 1,2,3-triazole-pyramidine hybrid derivatives and screened their cytotoxic potential towards several tumour cell lines. Among these synthesized compounds, the compound 44a exhibited the potent and selective anti-proliferative activity with IC 50 values in range between 1.42 and 6.52 μM. Particularly, studies revealed that the compound 44a also inhibit the growth of EC-109 cancer cells via apoptosis-inducing activity and cell cycle arrest at G2/M phase [73] .

Duan et al. synthesized a new series of 1,2,3-triazole-dithiocarbamate hybrids and screened their anticancer activity against four different selected human cancer cell lines including MCF-7, PC-3, MGC-803, and EC-109. Among these, the compounds 45a and 45b showed significant wide-spectrum activity. Compound 45a was found to be most potent towards selected four different human cancer cell lines as compared with 5-fluorouracil [74] .

Aouad et al. reported a novel series of benzothiazolepiperazine-1,2,3-triazole hybrids and investigated their anti-proliferative activity against different human cancer cell lines. Some hybrid molecules showed significant antiproliferative activity. ADME and clog P analysis method confirmed the biological profile. From the result, compound 46a exhibited the remarkable antiproliferative activity [75] .

Ashwin et al. reported a novel series of 1,2,3-triazole derivatives and screened their anticancer activity against acute myeloid leukemia cell lines. Result revealed that, compound 47a exhibited the significant anticancer activity with an IC 50 of 2 μM towards MV4-11 cells [76] . different tumour cell lines. From the result, compound 49a with the shortest alkyl substituent at the triazole ring showed significant inhibitory activity against the CaCo-2 cell line but low cytotoxic effect on normal MDCK I cells [78] .

Saeedi et al. reported the quinazolinone-1,2,3-triazole hybrid derivatives and screened their in vitro αglucosidase inhibitory activity as leading to an effective antidiabetic agent. All these derivatives displayed excellent antidiabetic activity with IC 50 values ranging between 181.0 and 474.5 μM and were found to be more potent than reference drug acarbose (IC 50 Avula et al. synthesized a class of novel 1,2,3-triazole analogues were synthesized and evaluated their αglucosidase inhibitory activity in ranges between 14.2 and 218.1 μM. Result revealed that the compound 51a exhibited the most effective antidiabetic activity as compared with the reference drug. And the activity of this compound is 67 times better than the reference due to the presence of the methoxy phenyl group [80] .

Wang et al. synthesized a novel series of triazinetriazole derivatives and evaluated their antidiabetic activity. All these derivatives exhibited the potent antidiabetic activity. Out of all synthesized compounds, compound 52a showed potent α-glucosidase inhibitory activity [14] .

Chinthala et al. reported a novel series of chalcone-1, 2,3-triazole hybrids and screened their α-glucosidase inhibitor activity. These hybrids exhibited the potential antidiabetic activity. Result showed that the compounds 53a, 53b, and 53c with IC 50 values of 67.77 μM, 74.94 μM, and 102.10 μM, respectively, exhibited potent αglucosidase inhibition. Furthermore, the docking studies showed these compounds target the α-glucosidase in range 100.37 to 107.78 [81] .

Gonzaga et al. synthesized 1-phenyl-1H-2-phenyl-2H-1,2,3-triazol derivatives and screened their α-glucosidase and porcine pancreatic α-amylase activity. All compounds tested at 500 μM, only compound 54a was found to have the most significant antidiabetic activity with 54 μM as compared with acarbose [82] . Kucukguzel et al. investigated a new series of novel thiourea containing triazole derivatives and tested their anti-HIV activity. Structures of synthesized derivatives were confirmed by elemental and spectral analysis. Result revealed that the compound 57a exhibited the significant anti-HIV activity towards Coxsackie virus B4. SAR studies revealed that, the presence of the allyl group at N-4 of the 1,2,4-triazole ring and phenyl ring at terminal nitrogen of thioureas enhanced their activity [85] .

Wang et al. reported a novel series of sulfanyl-triazole derivatives as an HIV-1 non-nucleoside reverse transcriptase inhibitor by using high throughput screening. It exhibited significant activities against the selected resistant mutants. From the result, compound 58a exhibited excellent anti-HIV activity [86] .

Karypidou et al. synthesized a series of fused 1,2,3triazole derivatives as potential antiviral agent. All the derivatives were screened against some variety of viruses (HIV-1, HIV-2, vaccinia virus, adenovirus-2, and coronavirus) in HEL cells and their inhibitory activity was compared with standard drugs. Among all the tested series, compound 59a (EC 50 = 8.95 μM) and 59b (EC 50 = 8.90 μM) exhibited the moderate activity against human coronavirus [87] . Cao et al. synthesized novel triazole derivatives for in vitro antiviral activity against EV71 and CVB3 in cellbased assay. All the synthesized derivatives were characterized by various spectroscopic methods including 1 H NMR, 13 C NMR, and mass spectroscopy. Among the result, only compound 60a exhibited remarkable antiviral activities against EV71 and CVB3 virus with the EC 50 value of 5.3 ± 0.7 and 10.1 ± 3.8 μg/mL as compared with the control ribavirin [88] .

Mohammed et al. reported 1,2,3-triazoles as amide bio-isosteres and evaluated for their antiviral activity against H9 and MT4 cells. Result revealed that the 1,4disubstituted-1,2,3-triazole based derivatives 61a was found to have significant anti-HIV activity against only H9 cells (IC 50 = 1.2 μM in H9 cells) and no activity against MT4 cells [89] .

Oramas-Royo et al. reported and investigated a new series of 1,2,3-triazole-napthaquinone derivatives. Several of these compounds were tested for their in vitro antimalarial activity towards Plasmodium falciparum strains. From the result, compounds 62a and 62b exhibited potent antimalarial activity with IC 50 values of 0.8 and 1.2 μM. SAR studies revealed that the compound 62a bearing a fluoro group at C-3 and a methoxy group at C-4 and compound 62b with an unsubstituted phenyl ring enhanced the antimalarial activity [90] .

Thakur et al. synthesized a novel series of glycosylated 1,2,3-triazolyl-methyl-indoline-2,3-dione derivatives via acid catalyzed reaction and evaluated their anti-plasmodial activity. Among them, compounds 63a and 63b exhibited the good activity against resistant strain pfk1 with IC 50 values 1.61 and 1.93 μM, respectively [91] .

Thakkar et al. reported new ten compounds containing 1,2,4-triazole and evaluated their in vitro antimalarial activity against P. falciparum strain. All these synthesized derivatives were characterized by IR, 1 H NMR, 13 C NMR, mass spectroscopy, and elemental analysis. From the result, compounds 64a, 64b, and 64c exhibited the potent antimalarial activity with IC 50 values 0.282, 0.245, and 0.230 μM as compared with the reference drug chloroquine Pyrimethamine. SAR studies revealed that introduction of 4-OH, 3-NO 2, 4-CL in the phenyl group enhance activity [92] .

Joshi et al. synthesized a novel series of quinoline triazole amide analogues and screened for their antimalarial activity against different strains (CQS D10 and CQR K1). It was concluded that the compounds 65a, 65b, and 65c showed most potent activity towards P. falciparum CQS D10 strain with IC 50 values in the range between 349 and 1247 μM, and these compounds also exhibited similar activity against CQR K1 strain of parasite [93] .

Guantai et al. synthesized a new triazole-linked chalcone and dienone hybrids and evaluated in vitro antimalarial activity. From the result, compound 66a was found to have the most significant activity against D10, DD2, and W2 strains of P. falciparum as compared with the reference drug chloroquine [94] . Tarawneh et al. synthesized a novel series of isoxazole and triazole derivatives and evaluated for their anti-infective agent. All the compounds were screened against P. falciparum D6 and W2 strains. From the result, the only compound 67a exhibited the most potent activity with IC 50 values of 0.70 and 0.59 μM against D6 and W2 strains [95] .

In spite of all these activities, triazoles are also active as antihypertensive agent 68a, neuroprotective agents 68b and 68c, and diuretic 68d (Table 3) . Triazole nucleus was found to possess significant atypical behaviour and good potency to block 5-HT receptors and good ability of selective antagonists towards the human vasopressin V 1A receptor [96] [97] [98] [99] .

This review article highlights research work of many researchers reported in literature for different pharmacological activities on triazole compounds. Triazole has unique moiety that is responsible for various biological activities. The importance of triazole moiety can be magnified by carrying out further studies on its possible substitution and thus to synthesize better agents that can have strong future commitments. This review has presented comprehensive details of triazole analogues, potent compounds reported for particular pharmacological activity and the method or technique involved in evaluation process. More investigations must be carried out to evaluate more activities of triazole for many diseases whose treatment are difficult in the medical sciences. 

We declare that this work was done by the authors named in this article: SLK conceived and designed the study. SK carried out the literature collection of the data and writing of the manuscript. AY and SK assisted in the data analysis and corrected the manuscript. The authors read and approved the final manuscript.

Availability of data and materials All the information in the manuscript has been referred from the included references and is available upon request from the corresponding author.

Ethics approval and consent to participate Not applicable Consent for publication Not applicable

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent

3-Triazole-containing hybrids as leads in medicinal chemistry: a recent overview

Synthesis of novel Nheterocyclic compounds containing 1,2,3-triazole ring system via domino

The chemistry of 1, 2, 4-triazoles

Facile synthesis of new imidazo[1,2-a]pyridines carrying 1,2,3-triazoles via click chemistry and their antiepileptic studies

Triazolines. 14. 1,2,3-Triazolines and triazoles, a new class of anticonvulsants. Drug design and structure-activity relationships

Synthesis of some quinoline-2(1H)-one and 1, 2, 4-triazolo [4, 3-a] quinoline derivatives as potent anticonvulsants

Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles

Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies

Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase

Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication

Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain

Synthesis of 5-(2-,3-and 4-methoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives exhibiting anti-inflammatory activity

Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential alpha-glucosidase inhibitors

Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives

Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues

Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent

Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives

Synthesis of 4-aminoquinoline-1,2,3-triazole and 4-aminoquinoline-1,2,3-triazole-1,3,5-triazine hybrids as potential antimalarial agents

Triazole derivatives and their antiplasmodial and antimalarial activities

Catalyst-free synthesis of 4-acyl-NH-1,2,3-triazoles by water-mediated cycloaddition reactions of enaminones and tosyl azide

Microwave-assisted catalyst-free synthesis of substituted 1, 2, 4-triazoles

One-pot synthesis of 3,4,5-trisubstituted 1,2,4-triazoles via the addition of hydrazides to activated secondary amides

Highly efficient cyanoimidation of aldehydes

One-pot synthesis of 1,4-disubstituted 1,2,3-triazoles from in situ generated azides

I2-catalyzed oxidative coupling reactions of hydrazones and amines and the application in the synthesis of 1,3,5-trisubstituted 1,2,4-triazoles

Synthesis and antibacterial evaluation of Mannich bases derived from 1,2,4-triazole

Design, synthesis and antibacterial activity of coumarin-1,2,3-triazole hybrids obtained from natural furocoumarin peucedanin

Design, synthesis, and anti-bacterial evaluation of triazolyl-pterostilbene derivatives

Design, synthesis, and in vitro antifungal evaluation of novel triazole derivatives bearing alkynyl side chains

Synthesis of novel (E)-2-(4-(1H-1,2,4-triazol-1-yl)styryl)-4-(alkyl/arylmethyleneoxy)quinazoline derivatives as antimicrobial agents

Synthesis of novel 2,5-disubstituted-1,3,4-thiadiazoles clubbed 1,2,4-triazole, 1,3,4-thiadiazole, 1,3,4-oxadiazole and/or Schiff base as potential antimicrobial and antiproliferative agents

Synthesis and antimicrobial activity of new 1,2,4-triazole and 1,3,4-thiadiazole derivatives

Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3

Synthesis, antibacterial activity and molecular docking study of vanillin derived 1,4-disubstituted 1,2,3-triazoles as inhibitors of bacterial DNA synthesis

Novel triazole derivatives containing different ester skeleton: design, synthesis, biological evaluation and molecular docking

Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1, 2, 3-triazolesulfonamide hybrids as antimicrobial and antiproliferative agents

Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach

One-pot synthesis of new triazole-Imidazo[2, 1-b][1, 3, 4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity

Synthesis and biological evaluation of 1H-pyrrolo [2, 3-d] pyrimidine-1, 2, 3-triazole derivatives as novel anti-tubercular agents

Synthesis, biological evaluation and molecular dynamics studies of 1,2,4-triazole clubbed Mannich bases

Synthesis and biological evaluation of novel 1, 2, 3-triazole derivatives as anti-tubercular agents

Synthesis, spectral characterization and anthelmintic evaluation of some novel imidazole bearing triazole derivatives

Synthesis, in vitro antioxidant, anthelmintic and molecular docking studies of novel dichloro substituted benzoxazole-triazolo-thione derivatives

Antimicrobial and anthelmintic activities of some newly synthesized triazoles

Design, synthesis and biological activity of some 4, 5-disubstituted-2, 4-dihydro-3H-1, 2, 4-triazole-3-thione derivatives

Synthesis and evaluation of anticonvulsant activities of 7

Synthesis and pharmacological evaluation of new 3,4-dihydroisoquinolin derivatives containing heterocycle as potential anticonvulsant agents

Synthesis of two novel 3-amino-5-[4-chloro-2-phenoxyphenyl]-4H-1,2,4-triazoles with anticonvulsant activity

Synthesis and evaluation of the anticonvulsant activities of 4-(2-(alkylthio)benzo[d]oxazol-5-yl)-2,4-dihydro-3H-1,2,4-triazol-3-ones

Design, synthesis, in vivo and in silico evaluation of phenacyl triazole hydrazones as new anticonvulsant agents

Synthesis and anticonvulsant activity of 7-phenyl-6,7-dihydro

Triazole incorporated thiazoles as a new class of anticonvulsants: design, synthesis and in vivo screening

Design, synthesis and anticonvulsant activity evaluation of novel 4-(4-substitutedphenyl)-3-methyl-1H-1,2,4-triazol-5(4H)-ones

Synthesis, anti-inflammatory, p38alpha MAP kinase inhibitory activities and molecular docking studies of quinoxaline derivatives containing triazole moiety

Analgesic and anti-inflammatory potential of merged pharmacophore containing 1, 2, 4-triazoles and substituted benzyl groups via thio linkage

Synthesis, molecular docking with COX 1& II enzyme, ADMET screening and in vivo anti-inflammatory activity of oxadiazole, thiadiazole and triazole analogs of felbinac

Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole

Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modeling studies

Synthesis and analgesic activity of new 1, 3, 4-oxadiazoles and 1, 2, 4-triazoles

Synthesis of novel 1,2,3-triazole based benzoxazolinones: their TNF-alpha based molecular docking with invivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation

Synthesis of novel 2-mercapto benzothiazole and 1,2,3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities

Novel 1-[4-(aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies

Preparation of 5-aryl-3-alkylthio-l,2,4-triazoles and corresponding sulfones with antiinflammatoryanalgesic activity

) 1,4-Diaryl-substituted triazoles as cyclooxygenase-2 inhibitors: synthesis, biological evaluation and molecular modeling studies

Synthesis, biological evaluation and computational studies of fused acridine containing 1, 2, 4-triazole derivatives as anticancer agents

Synthesis of novel 1, 2, 4-triazolyl coumarin derivatives as potential anticancer agents

Design and synthesis of novel 1,2,3-triazolepyrimidine hybrids as potential anticancer agents

Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents

Design, synthesis and anticancer screening of novel benzothiazole-piperazine-1,2,3-triazole hybrids

Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation

Synthesis, cytotoxicity and antimicrobial evaluation of new coumarin-tagged beta-lactam triazole hybrid

Synthesis and in vitro evaluation of antiviral and cytostatic properties of novel 8-triazolyl acyclovir derivatives

Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro alpha-glucosidase inhibition, kinetic, and docking study

Synthesis of 1H-1,2,3-triazole derivatives as new alpha-glucosidase inhibitors and their molecular docking studies

ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity

1-Phenyl-1H-and 2-phenyl-2H-1, 2, 3-triazol derivatives: design, synthesis and inhibitory effect on alpha-glycosidases

Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity

Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture

Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents

Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 nonnucleoside reverse transcriptase inhibitors

Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents

Asymmetric synthesis of novel triazole derivatives and their in vitro antiviral activity and mechanism of action

3-Triazoles as amide bioisosteres: discovery of a new class of potent HIV-1 Vif antagonists

Synthesis and antiplasmodial activity of 1,2,3-triazole-naphthoquinone conjugates

Synthesis and antiplasmodial activity of glyco-conjugate hybrids of phenylhydrazono-indolinones and glycosylated 1,2,3-triazolyl-methylindoline-2,3-diones

1,2,4-Triazole and 1,3,4-oxadiazole analogues: synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities

In vitro antimalarial activity, beta-haematin inhibition and structure-activity relationships in a series of quinoline triazoles

Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds

Evaluation of triazole and isoxazole derivatives as potential anti-infective agents

Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity

Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates

Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: synthesis, neuronal cell culture investigations, and CDK5 docking studies

New generation azole antifungals in clinical investigation

Voriconazole therapeutic drug monitoring

Efficacy of anastrozole in male breast cancer

The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit

Migraine pharmacotherapy with oral triptans: a rational approach to clinical management

Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor

Ribavirin's antiviral mechanism of action: lethal mutagenesis?

Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons

Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam

Successful treatment of alcohol withdrawal with trazodone

Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders

Alprazolam-related deaths in Palm Beach County

The authors declare that they have no competing interests.Received: 5 January 2021 Accepted: 3 April 2021